Indication: 1. Candidiasis: used to treat oropharyngeal and esophageal Candida infections; disseminated Candidiasis, including peritonitis, pneumonia, urinary tract infections, etc.; Candida vulvovaginitis. It can also be used to prevent Candida infections in bone marrow transplant patients receiving cytotoxic drugs or radiotherapy. 2. Cryptococcosis: used to treat new cryptococcosis other than meninges; when treating cryptococcal meningitis, this product can be used as a maintenance therapy after initial treatment with amphotericin B combined with flucytosine. 3. Coccidioidomycosis. 4. Used for preventive treatment of patients receiving chemotherapy, radiotherapy and immunosuppressive therapy. 5. This product can also replace itraconazole for the treatment of blastomycosis and histoplasmosis.

Indication: 1. Candidiasis: used to treat oropharyngeal and esophageal Candida infections; disseminated Candidiasis, including peritonitis, pneumonia, urinary tract infections, etc.; Candida vulvovaginitis. It can also be used to prevent Candida infections in bone marrow transplant patients receiving cytotoxic drugs or radiotherapy; 2. Cryptococcosis: used to treat new cryptococcosis other than meninges; when treating cryptococcal meningitis, this product can be used as a maintenance therapy after initial treatment with amphotericin B combined with flucytosine; 3. Coccidioidomycosis; 4. Used for preventive treatment of patients receiving chemotherapy, radiotherapy and immunosuppressive therapy; 5. This product can also replace itraconazole for blastomycosis and histoplasmosis

Indication: 1. Candidiasis: used to treat oropharyngeal and esophageal Candida infections; disseminated Candidiasis, including peritonitis, pneumonia, urinary tract infections, etc.; Candida vulvovaginitis. It can also be used to prevent Candida infections in bone marrow transplant patients receiving cytotoxic drugs or radiotherapy; 2. Cryptococcosis: used to treat new cryptococcosis other than meninges; when treating cryptococcal meningitis, this product can be used as a maintenance therapy after initial treatment with amphotericin B combined with flucytosine; 3. Coccidioidomycosis; 4. Used for preventive treatment of patients receiving chemotherapy, radiotherapy and immunosuppressive therapy; 5. This product can also replace itraconazole for the treatment of blastomycosis and histoplasmosis.

Indication: This product is mainly used for patients with more serious conditions in the following indications: 1. Candidiasis: used to treat oropharyngeal and esophageal Candida infections; disseminated Candidiasis, including peritonitis, pneumonia, urinary tract infections, etc.; Candida vulvovaginitis. It can also be used to prevent the occurrence of Candida infections in bone marrow transplant patients receiving cytotoxic drugs or radiotherapy. 2. Cryptococcosis: used to treat new cryptococcosis other than meninges; when treating cryptococcal meningitis, this product can be used as a maintenance therapy after initial treatment with amphotericin B combined with flucytosine. 3. Coccidioidomycosis. 4. This product can also replace itraconazole for the treatment of blastomycosis and histoplasmosis.

Indication: This product is mainly used for patients with more severe conditions in the following indications: 1. Candidiasis: used to treat oropharyngeal and esophageal Candida infections; disseminated Candidiasis, including Candida vulvovaginitis such as peritonitis, pneumonia, and urinary tract infections. It can also be used to prevent the occurrence of Candida infections in bone marrow transplant patients receiving cytotoxic drugs or radiotherapy. 2. Cryptococcal disease: used to treat new cryptococci other than meninges; when treating cryptococcal meningitis, this product can be used as a maintenance treatment after initial treatment with amphotericin B combined with flucytosine. 3. Coccidioidomycosis. 4. This product can also replace itraconazole for the treatment of blastomycosis and histoplasmosis.

Indication: This product can be used for empirical treatment of patients with neutropenia and fever suspected of fungal infection. This product can also be used to treat the following systemic fungal infections: 1. Aspergillosis. 2. Candidiasis. 3. Cryptococcal disease (including cryptococcal meningitis); for immunocompromised patients with cryptococcosis and all patients with central nervous system cryptococcosis, this product can only be used for treatment when first-line drugs are not applicable or ineffective; 4. Histoplasmosis. Before treatment, fungal specimens should be collected and other relevant laboratory tests (wet smears, histopathology, serology) should be performed to isolate and identify pathogenic microorganisms. Treatment can be carried out before the results of culture and other laboratory tests are obtained; once meaningful test results are obtained, antifungal treatment should be adjusted accordingly.

Indication: 1. Systemic fungal infections, such as systemic candidiasis, paracoccidioidomycosis, histoplasmosis, coccidioidomycosis and blastomycosis. 2. Infections of the skin, hair and nails caused by dermatophytes and/or yeasts (tinea dermatophytes, onychomycosis, candidal perionychia, tinea versicolor, pityriasis dryis, Malassezia folliculitis, chronic skin and mucosal candidiasis, etc.). This product can be used for treatment when local treatment is ineffective or when topical treatment is not suitable due to factors such as the site, area and depth of infection. 3. Gastrointestinal yeast infections. 4. Chronic and recurrent vaginal candidiasis that is ineffective with local treatment. 5. It can also be used for the prevention and treatment of patients who are prone to opportunistic fungal infections due to reduced immune function (hereditary and caused by diseases or drugs). This product has poor penetration into the central nervous system and is not suitable for the treatment of fungal meningitis.

Indication: Systemic fungal infections, such as systemic candidiasis, paracoccidioidomycosis, and histoplasmosis. This drug can be used to treat infections of the skin, hair, and nails (dermatophytes, onychomycosis, perionychia, tinea versicolor, chronic skin and mucosal candidiasis, etc.) caused by dermatophytes and/or yeasts when local treatment is ineffective or it is difficult to apply the drug due to factors such as the site, area, and depth of infection. Gastrointestinal yeast infections. Chronic and recurrent vaginal candidiasis that is ineffective with local treatment. Used for the prevention and treatment of patients who are susceptible to fungal infections due to reduced immune function (hereditary and caused by disease or drugs). This product has poor penetration into the central nervous system and is not suitable for the treatment of fungal meningitis.

Indication: Systemic fungal infections, such as systemic candidiasis, paracoccidioidomycosis, and histoplasmosis. This drug can be used to treat infections of the skin, hair, and nails (dermatophytes, onychomycosis, perionychia, tinea versicolor, chronic skin and mucosal candidiasis, etc.) caused by dermatophytes and/or yeasts when local treatment is ineffective or it is difficult to apply the drug due to factors such as the site, area, and depth of infection. Gastrointestinal yeast infections. Chronic and recurrent vaginal candidiasis that is ineffective with local treatment. Used for the prevention and treatment of patients who are susceptible to fungal infections due to reduced immune function (hereditary and caused by disease or drugs). This product has poor penetration into the central nervous system and is not suitable for the treatment of fungal meningitis.

Indication: This product is mainly used for patients with more severe conditions in the following indications: 1. Candidiasis: used to treat oropharyngeal and esophageal Candida infections; disseminated Candidiasis, including Candida vulvovaginitis such as peritonitis, pneumonia, and urinary tract infections. It can also be used to prevent the occurrence of Candida infections in bone marrow transplant patients receiving cytotoxic drugs or radiotherapy. 2. Cryptococcal disease: used to treat new cryptococci other than meninges; when treating cryptococcal meningitis, this product can be used as a maintenance treatment after initial treatment with amphotericin B combined with flucytosine. 3. Coccidioidomycosis. 4. This product can also replace itraconazole for the treatment of blastomycosis and histoplasmosis.